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The inflammasome has been mainly studied in innate immune cells in which it senses
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microbes and cellular damage, and induces secretion of pro-inflammatory cytokines. This
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process induces an inflammatory response that is critical for the resolution of infections
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and repair of tissue damage following injury. Recent studies indicate that inflammasome
complex formation also participates in many other cellular and physiological processes
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The inflammasome has been mainly studied in innate immune cells in which it senses microbes and cellular damage,
activates caspase-1, and induces secretion of the proinflammatory cytokines interleukin (IL)-1b and IL-18 [see Box
1 and Fig. 1A] [1e3]. This process stimulates an inflammatory response that is critical for the resolution of infections
and repair of tissue damage following injury. The inflammasome is thus involved in various diseases associated with
chronic inflammation, including Alzheimer's disease,
atherosclerosis, cancer, gout, inflammatory bowel disease,
microbial infections, and type 2 diabetes [1e3]. Recent studies
indicate that inflammasome complex formation participates
in many other cellular and physiological processes beyond
modulation of inflammation, such as autophagy, metabolism,
eicosanoids production, and phagosome maturation [4].
Autophagy has been recognized as an important cellular
process involving the destruction and recycling of unnecessary or dysfunctional proteins and organelles. Autophagy
inhibits inflammasome activation by removing damaged
mitochondria which produce inflammasome-activating reactive oxygen species (ROS) [5,6]. Furthermore, autophagy mediates the removal of inflammasome complexes, thereby
inhibiting caspase-1 activation [7]. Conversely, inflammasome
activation inhibits autophagy. For instance, when macrophages are infected with Shigella flexneri bacteria, activation of
the NLCR4 inflammasome and caspase-1 inhibits autophagy
and autophagosome formation [8]. Given that autophagy is
normally associated with cell survival in response to stress
whereas inflammasome activation is associated with rapid
demise of the cell (as when pyroptosis occurs), regulation of
these processes may determine cellular fate in response to
environmental stimuli.
A recent study showed that autophagy is involved in IL1b secretion following activation of the AIM2 inflammasome [9]. Activation of AIM2, which forms a caspase-1activating inflammasome upon binding to cytosolic DNA,
was shown to engage end-binding protein 1 (EB1), leading
to co-localization with the microtubule-organizing center

(MTOC) and incorporation within autophagosomes
destined for secretion. Another study showed that the
NLRP3 inflammasome binds to the centrosome-associated
proteins tubulin and centrin in a caspase-1-dependent
manner [10]. Interaction between these proteins leads to
breakdown of the microtubule network, a process that
may be required for inflammasome-mediated cell death by
pyroptosis.
Metabolism is also associated with inflammasome activation. A proteomic-based search for the substrates of caspase-1
identified many glycolysis enzymes such as aldolase, triosephosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase, a-enolase, and pyruvate kinase [11]. The authors of
this study suggested that inhibition of glycolysis in bacteriainfected cells may lead to cell death and limit the growth of
intracellular bacteria. Moreover, caspase-1 can activate sterol
regulatory element-binding proteins (SREBPs) in cells treated
with bacterial pore-forming toxins [12]. In this context, activation of SREBPs, which activate transcription of genes
involved in cholesterol and fatty acid biosynthesis, was
associated with repair of the plasma membrane following
damage by pore-forming toxins.
Eicosanoids are lipid molecules that include leukotrienes,
prostaglandins, and thromboxanes. Produced from 20-carbon
fatty acids, they are involved in various physiological functions such as inflammation, immunity against pathogens,
pain sensation, smooth muscle contraction, and vasodilation.
Stimulation of the NLRP1 and NLRC4 inflammasomes activates caspase-1, which in turn leads to membrane pore formation, intracellular calcium influx, and phospholipase A2
activation [13]. This enzyme releases arachidonic acid from
phospholipids present in the cell membrane. Arachidonic acid
is converted into active eicosanoids by cyclooxygenase and
lipoxygenases. This “eicosanoid storm” is produced mainly by
peritoneal macrophages and is associated with vasodilation,
fluid loss from blood, diarrhea, hypothermia and even death
in response to inflammasome triggers such as bacterial lipopolysaccharide (LPS) [13]. Notably, this inflammatory response

Box 1
Canonical inflammasome activation
Inflammasomes are intracellular protein complexes that contain an immune sensor protein (e.g., AIM2, NLRC4, NLRP1, or
NLRP3), caspase-1, and, in many cases, the adaptor protein ASC. Some inflammasomes are directly activated by pathogenassociated molecular patterns (PAMPs). For example, the AIM2 inflammasome is activated by cytosolic double-strand
DNA, whereas NLRC4 is stimulated by bacterial flagellin. In contrast, the NLRP3 inflammasome is activated by a wide
range of stimuli, including PAMPs such as lipopolysaccharide (LPS), as well as danger-associated molecular patterns (DAMPs)
including extracellular adenosine triphosphate (ATP) and uric acid crystals. The observation that diverse stimuli activate the
NLRP3 inflammasome suggests that PAMPs and DAMPs may not interact with NLRP3 but may instead activate the inflammasome indirectly via other cellular pathways such as potassium efflux or production of reactive oxygen species (ROS).
Two signals are usually needed to induce secretion of IL-1b and IL-18 in innate immune cells. The first signal may
represent a PAMP such as LPS which binds to a Toll-like receptor (TLR), leading to activation of NF-kB and expression of proIL-1b and pro-IL-18. The second signal may consist of a DAMP such as ATP which is released from damaged or stressed cells.
In this case, ATP may bind to the purinergic receptor P2X7 and result in inflammasome complex formation, activation of
caspase-1, and cleavage and secretion of active IL-1b and IL-18. These cytokines induce inflammation not only in response to
tissue injury or metabolic perturbations but also following contact with microbes and environmental toxins. For this reason,
inflammasome activation has been linked with a wide range of diseases associated with chronic inflammation (e.g.,
atherosclerosis, cancer, infection, obesity, and type 2 diabetes).
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Fig. 1 e Mode of activation of the inflammasome and immune sensory proteins. (A) Pathogen-associated molecular patterns
(PAMPs) and danger-associated molecular patterns (DAMPs) may induce potassium (Kþ) efflux and production of reactive
oxygen species (ROS) which in turn induce formation of the inflammasome complex (containing NLRP3 in the case depicted
here). Canonical inflammasome activation leads to activation of caspase-1 which converts pro-IL-1b and pro-IL-18 into their
active forms. The pro-inflammatory cytokines are secreted by the cell and may induce an inflammatory response. (B) Noncanonical inflammasome activation may involve bacterial lipopolysaccharide (LPS) which binds and activates caspase-11 in
mice (or caspase-4/5 in humans). One substrate of this enzyme is gasdermin, whose cleaved N-terminus induces cell death by
pyroptosis via a mechanism that remains to be elucidated. (C) Immune sensory proteins such as AIM2 also have
inflammasome-independent functions. In the case illustrated here, AIM2 inhibits Akt, preventing the effect of the latter protein
on cell survival and leading to cell death by apoptosis.
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Fig. 2 e Alternative functions of inflammasomes and immune sensory proteins.
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is independent of IL-1b and IL-18, which are commonly
secreted in response to inflammasome activation.
The inflammasome also contributes to phagosome maturation. The NLRP3 inflammasome is activated following
phagocytosis of bacteria by macrophages, possibly due to the
cytosolic production of ROS by the NADPH oxidase Nox2 [14].
Activated caspase-1 molecules accumulate on phagosomes
harboring bacteria, leading to assembly of the NADPH oxidase
complex on the phagosomal membrane. The NADPH enzyme
then acidifies the lumen of the phagosome, activating proteases that degrade bacterial proteins [14]. The NLRP3
inflammasome therefore participates in the killing of bacteria
engulfed by macrophages.
The inflammasome also plays important functions in
epithelial cells, which have attracted less attention than cells
of hematopoietic origin (reviewed recently [15]). In this
context, the inflammasome may induce processing of proinflammatory cytokines in response to pathogens and
cellular damage, similar to its role in innate immune cells. On
the other hand, activation of the inflammasome in epithelial
cells is involved in other cellular and physiological processes,
including tissue repair and regulation of pathogen growth. For
instance, mice that are deficient in the inflammasome
component NLRP3 show reduced healing in response to
cutaneous wounds [16]. In addition, our group has reported
that Chlamydia trachomatis shows reduced growth in the
absence of caspase-1 in human HeLa cervical cancer cells [17].
These studies demonstrate that the functions of inflammasomes are by no means limited to pro-inflammatory functions
in innate immune cells.
Recent evidence indicates that inflammasome components are required for several functions independently of
their capacity to form inflammasome complexes. For
instance, NLRP3 binds to the transcription factor IRF4 in
CD4þ T cells, leading to activation of the Th2 cell differentiation program [18]. Accordingly, mice lacking NLRP3 show
reduced growth of melanoma tumors and lower levels of
asthma-like symptoms compared to wild-type mice, and
these effects are due to NLRP3 deficiency in CD4þ T cells but
not in myeloid cells. Furthermore, AIM2 inhibits the proliferation of colon tumors by preventing activation of Akt
[Fig. 1C], an important regulator of cell survival and proliferation [19].
IL-1b and IL-18 were initially thought to be secreted due
to a simple two-step mechanism involving detection of the
microbial product, followed by danger-induced activation of
an inflammasome and caspase-1 [Box 1] [1e3]. Subsequently, non-canonical and alternative inflammasomes
involving caspase-11 or caspase-8 were described [Fig. 1B]
[20e22]. Finally, the inflammasomes are now known to play
many roles that are unrelated to inflammation [Fig. 2].
Perhaps it is time to specify which inflammasome activity is
being characterized, such as the metabolic inflammasome or
inflammatory inflammasome, or to rename this protein complex with a broader term corresponding to its broader
functions. Even without a new name, this awesome protein
complex is certain to reveal more novel functions in the
future.
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